marketreportsupdates (105)

1
Antibiotics Market To Reach USD 63.34 Billion By
2026
www.reportsanddata.com
sales_at_reportsanddata.com
2
Market Summary
Increase in number of chronic diseases coupled
with technological advancements globally, are the
major factors influencing market growth. Market
Size USD 46.23 billion in 2018, Market Growth -
CAGR of 3.9, Market Trends Technological
advancement along with increasing chronic
diseases The Antibiotics Market is estimated to
reach USD 63.34 Billion by 2026, according to a
new report by Reports and Data. This can be
mainly associated with the growing incidences of
infectious diseases such as pneumonia, HIV/AIDS,
malaria, and tuberculosis along with
technological advancements that are expected to
become the most common growth factors globally in
the coming years.
3
Our Approach
Market Summary

• Expanding efforts initiated by the key companies
  for the development of advanced products will
  boost market growth. A report by the Pew
  Charitable Trust states, about 37 promising
  molecules were investigated within the U.S.
  market in March 2016. Majority of which are in
  clinical trials phase II and are expected to hit
  the market in the coming years. Moreover,
  supportive government enactments, such as the
  GAIN (Generating Antibiotics Incentives Now) Act,
  is anticipated to facilitate the approval
  process.
• GAIN Act has plans, which promote the advancement
  of therapies against antibiotic-resistant
  pathogens. Diarrhea is one of the leading causes
  of death among children across the globe, and it
  requires antibiotic mediation to reduce the death
  rate. Other infectious diseases that may boost
  the growth of the market are pneumonia, HIV/AIDS,
  malaria, and tuberculosis. Moreover, the
  development of new infections, such as the Ebola
  virus and Zika, are also promoting the
  development and growth of the antibiotics market.
• Due to the presence of key players, favorable
  reimbursement policies, and rising number of
  chronic diseases along with several initiatives
  taken by the governments, North America accounts
  for the largest share of 33.5 of the market in
  2018.
• Request for a sample of this research report _at_
  https//www.reportsanddata.com/sample-enquiry-form
  /1377

4
Our Approach
Market Summary

• Further key findings from the report suggest
• Antibiotics are a combination of medicines used
  in the treatment of infections or diseases caused
  by bacteria, germs, and some parasites-by
  restraining the growth of microorganisms or
  destroying them.
• Antibiotics are also named as antimicrobials or
  antibacterial.
• Increase in the prevalence of persistent and
  infectious diseases across the globe and the
  ability of antibiotics to treat a broad spectrum
  of bacterial infections have led to the
  accelerated growth of the global market.
• Since the development of the antibiotic
  penicillin in 1920, several antibiotic compounds
  have been used to treat various bacterial
  infections.
• Growing population, increasing rates of chronic
  diseases, and rising healthcare expenditures are
  the fundamental factors which are boosting the
  growth of the market across the globe.
• Development of various antiviral drugs, which
  hinder transcription and reverse transcription
  methods, are expected to boost the growth.
• To identify the key trends in the industry, click
  on the link below https//www.reportsanddata.com/
  report-detail/antibiotics-market

5
Our Approach
Market Summary

• Key participants include Bristol-Myers Squibb
  Co., AstraZeneca plc, The Menarini Group,
  GlaxoSmithKline plc, Bayer HealthCare AG, Eli
  Lilly and Company, Merck Co., Inc., Johnson
  Johnson, Novartis AG, Teva Pharmaceutical
  Industries Ltd., Sanofi
• For the purpose of this study, Reports and Data
  have segmented the global Antibiotics Market on
  the basis of Type, End user, Product,
  Administration mode and region
• By Type Outlook (Revenue, USD Million 2016-2026)
• RNA Synthesis Inhibitors
• DNA Synthesis Inhibitors
• Cell Wall Synthesis Inhibitors
• Protein Synthesis Inhibitors
• Mycolic Acid Inhibitors

6
Our Approach
Market Summary

• By End-User Outlook (Revenue, USD Million
  2016-2026)
• Retail pharmacies
• Online pharmacies
• Hospital pharmacies
• Product Outlook (Revenue, USD Million 2016-2026)
• Carbapenems
• Penicillin
• Fluoroquinolones
• Macrolides
• Others
• Order Now https//www.reportsanddata.com/checkout
  -form/1377

7
About Us
Our Approach
About Us

• Reports and Data is a market research and
  consulting company that provides syndicated
  research reports, customized research reports,
  and consulting services. Our solutions purely
  focus on your purpose to locate, target and
  analyze consumer behavior shifts across
  demographics, across industries and help clients
  make a smarter business decision. We offer market
  intelligence studies ensuring relevant and
  fact-based research across a multiple industries
  including Healthcare, Technology, Chemicals,
  Power, and Energy. We consistently update our
  research offerings to ensure our clients are
  aware about the latest trends existent in the
  market. Reports and Data has a strong base of
  experienced analysts from varied areas of
  expertise.
• Contact Us
• John Watson
• Head of Business Development
• Reports And Data Web www.reportsanddata.com
• Direct Line 1-212-710-1370
• E-mail sales_at_reportsanddata.com